Spruce Biosciences
Total Raised
$108MInvestors Count
9Deal Terms
2Funding, Valuation & Revenue
3 Fundings
Spruce Biosciences has raised $108M over 3 rounds.
Spruce Biosciences's latest funding round was a IPO for $75M on October 9, 2020.
Spruce Biosciences's valuation in April 2016 was $50.69M.
Spruce Biosciences's latest post-money valuation is from October 2020.
Sign up for a free demo to see Spruce Biosciences's valuations in October 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/9/2020 | IPO | $75M | 1 | |||
2/20/2020 | Series B | |||||
4/1/2016 | Series A | $50.69M |
Date | 10/9/2020 | 2/20/2020 | 4/1/2016 |
|---|---|---|---|
Round | IPO | Series B | Series A |
Amount | $75M | ||
Investors | |||
Valuation | $50.69M | ||
Revenue | |||
Sources | 1 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Spruce Biosciences Deal Terms
2 Deal Terms
Spruce Biosciences's deal structure is available for 2 funding rounds, including their IPO from October 09, 2020.
Round | IPO | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series A |
Spruce Biosciences Investors
9 Investors
Spruce Biosciences has 9 investors. RiverVest Venture Partners invested in Spruce Biosciences's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/1/2016 | 2/20/2020 | 2 Series A, Series B (2020) | Venture Capital | Missouri | ||
Corporate Venture | California | |||||
Private Equity | New York | |||||
Venture Capital | United Kingdom | |||||
Venture Capital | Virginia |
First funding | 4/1/2016 | ||||
|---|---|---|---|---|---|
Last Funding | 2/20/2020 | ||||
Investor | |||||
Rounds | 2 Series A, Series B (2020) | ||||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Private Equity | Venture Capital | Venture Capital |
Location | Missouri | California | New York | United Kingdom | Virginia |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Loading...